Angiodynamics Inc
ANGO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001275187
In the last 90 days, Angiodynamics Inc insiders filed 0 open-market purchases and 1 sale; 161 institutions reported holding it in 13F filings for Q2 2026, worth $492.8M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $344.0K in total
- 1
- 13F holdersQ2 2026, +15 vs. previous quarter
- 161
- 13F valueReported value at the end of Q2 2026
- $492.8M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ANGO, Q2 2026
No superinvestor reported holding ANGO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Angiodynamics Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 (view filing)4:45 PM ET | Jul 30 | 1 day | Nighan Warren JRSVP Quality and Regulatory | SSale | −23.4K | $14.72 | −$344.0K | −26.5%64.7K after | |
| Oct 22, 2025 (view filing) | Oct 21 | 1 day | Weiss Lawrence TSVP, Chief Legal Officer | PPurchase | +10.0K | $11.81 | +$118.1K | +12.0%93.6K after | |
| Oct 14, 2025 (view filing) | Oct 13 | 1 day | Trowbridge Stephen AEVP and CFO | PPurchase | +890 | $11.16 | +$9.93K | +0.3%256.6K after | |
| Oct 9, 2025 (view filing) | Oct 9 | Same day | Clemmer James CPresident and CEO | PPurchase | +10.0K | $11.15 | +$111.5K | +1.1%882.5K after | |
| Jan 17, 2025 (view filing) | Jan 16 | 1 day | Nighan Warren JRSVP Quality and Regulatory | SSale | −4.06K | $12.31 | −$50.0K | −8.8%41.8K after | |
| Oct 10, 2024 (view filing) | Oct 7-10 | 3 daysLate | Nighan Warren JRSVP Quality and Regulatory | PPurchase | +868 | $6.09 | +$5.29K | +1.9%45.9K after | 2 lots |
| Oct 8, 2024 (view filing) | Oct 8 | Same day | Trowbridge Stephen AEVP and CFO | PPurchase | +1.70K | $5.86 | +$9.96K | +1.0%172.7K after | |
| Oct 8, 2024 (view filing) | Oct 7 | 1 day | Clemmer James CPresident and CEO | PPurchase | +20.0K | $6.03 | +$120.6K | +3.0%681.6K after | 10b5-1 |
| Apr 8, 2024 (view filing) | Apr 8 | Same day | Clemmer James CPresident and CEO | PPurchase | +10.0K | $6.70 | +$67.0K | +1.9%539.1K after | |
| Feb 1, 2023 (view filing) | Jan 31 | 1 day | Helsel DaveSVP Global Operations and R&D | SSale | −4.63K | $12.95 | −$60.0K | −19.4%19.2K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Angiodynamics Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 3,803,232 | $49.5M | 0.00% | +117,328+3.2% | Added |
| Point72 Asset Management, L.P. | 3,062,517 | $39.8M | 0.06% | −119,312−3.7% | Reduced |
| Systematic Financial Management LP | 2,640,214 | $34.3M | 0.68% | +186,513+7.6% | Added |
| Armistice Capital, LLC | 2,198,000 | $28.6M | 0.79% | +329,000+17.6% | Added |
| Royce & Associates LP | 1,969,835 | $25.6M | 0.21% | +440,884+28.8% | Added |
| Broadfin Holdings LLC | 1,818,533 | $23.7M | 100.00% | −250,800−12.1% | Reduced |
| Vanguard Capital Management LLC | 1,694,716 | $22.0M | 0.00% | −32,104−1.9% | Reduced |
| Weber Capital Management LLC | 1,356,602 | $17.6M | 15.02% | −16,547−1.2% | Reduced |
| Nuveen, LLC | 1,199,358 | $15.6M | 0.00% | −16,807−1.4% | Reduced |
| Geode Capital Management, LLC | 1,020,658 | $13.3M | 0.00% | +35,235+3.6% | Added |